To Compare Brolucizumab to Aflibercept in Chinese Patients With Visual Impairment Due to Diabetic Macular Edema
Clinical trial NCT04058067 · COMPLETED
Trial details
- NCT number
- NCT04058067
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-23
- Primary completion
- 2023-01-31
- Enrollment
- 266
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.